Dextrose Injection Pharmaceutical Supply

The contract involves the supply and delivery of FDA-compliant Dextrose Injection, identified by NSN 6505015015408, for medical use, with all units required to be delivered FOB destination to Fort Bragg, North Carolina, no later than July 20, 2026. The product must meet all applicable regulatory standards for pharmaceutical safety and efficacy as mandated by the U.S. Food and Drug Administration, ensuring its suitability for clinical applications within military medical facilities. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and falls under NAICS code 325412, indicating manufacturing of pharmaceutical preparations. All deliveries are subject to strict FOB destination terms, meaning the vendor assumes full responsibility for transportation, risk, and costs until the goods are received at the designated location. The contract is tied to a specific procurement identifier and is part of the Defense Logistics Agency’s broader efforts to maintain critical medical inventory for U.S. military operations. The delivery deadline is firm, and compliance with federal pharmaceutical standards is non-negotiable, making adherence to packaging, labeling, and quality control requirements essential for contract fulfillment.